GT Biopharma, Inc. (GTBP)
0.299
-0.01
(-2.22%)
USD |
NASDAQ |
Aug 25, 16:00
0.299
0.00 (0.00%)
After-Hours: 17:13
GT Biopharma Shareholders Equity (Quarterly) : 3.569M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.569M |
| March 31, 2026 | 7.58M |
| December 31, 2025 | 5.787M |
| September 30, 2025 | 3.00M |
| June 30, 2025 | -23.92M |
| March 31, 2025 | -0.98M |
| December 31, 2024 | -1.67M |
| September 30, 2024 | 2.097M |
| June 30, 2024 | 5.508M |
| March 31, 2024 | 5.312M |
| December 31, 2023 | 7.476M |
| September 30, 2023 | 10.00M |
| June 30, 2023 | 11.76M |
| March 31, 2023 | 13.05M |
| December 31, 2022 | 11.73M |
| September 30, 2022 | 15.95M |
| June 30, 2022 | 15.44M |
| March 31, 2022 | 17.79M |
| December 31, 2021 | 21.91M |
| September 30, 2021 | 32.04M |
| June 30, 2021 | 36.46M |
| March 31, 2021 | 24.19M |
| December 31, 2020 | -29.26M |
| September 30, 2020 | -29.61M |
| June 30, 2020 | -27.33M |
| Date | Value |
|---|---|
| March 31, 2020 | -20.69M |
| December 31, 2019 | -19.14M |
| September 30, 2019 | -18.12M |
| June 30, 2019 | 9.145M |
| March 31, 2019 | 10.18M |
| December 31, 2018 | 11.54M |
| September 30, 2018 | 13.48M |
| June 30, 2018 | 246.23M |
| March 31, 2018 | 252.43M |
| December 31, 2017 | 251.86M |
| September 30, 2017 | 253.89M |
| June 30, 2017 | -19.92M |
| March 31, 2017 | -17.94M |
| December 31, 2016 | -18.76M |
| September 30, 2016 | -17.04M |
| June 30, 2016 | -15.66M |
| March 31, 2016 | -20.05M |
| December 31, 2015 | -50.40M |
| September 30, 2015 | -24.38M |
| June 30, 2015 | -22.73M |
| March 31, 2015 | -49.76M |
| December 31, 2014 | -29.40M |
| September 30, 2014 | -10.75M |
| June 30, 2014 | -6.814M |
| March 31, 2014 | -6.552M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.788M |
| Total Liabilities (Quarterly) | 2.219M |
| Current Ratio | 2.380 |